Search Results for 'Novartis, MorphoSys Expand Antibody Alliance'
Published December 3, 2007
Novartis and MorphoSys AG have formed a comprehensive, 10-year, $600 million strategic alliance for the discovery and development of biopharmaceuticals. The deal is aimed at establishing a pipeline of innovative drugs, and establishes Novartis as Mor… Read More »
Published June 26, 2006
MorphoSys AG expanded its therapeutic antibody collaboration with Novartis. The original collaboration agreement provided for a three-year term with an option for Novartis to extend. The collaboration will now go through May 2011. In May 2004,… Read More »
By James Grabowski, Manager, Sales Operations
AMRI is a global contract research and manufacturing organization offering integrated drug discovery, development, and manufacturing services. AMRI's experience, a track record of success and locations in North America, Europe and Asia provide ou… Read More »